Health & Beauty

The FINANCIAL -- AstraZeneca on October 23 announced that the US Food and Drug Administration (FDA) has approved Bydureon BCise (exenatide extended-release) injectable suspension, a new formulation of Bydureon in an improved once-weekly, single-dose autoinjector device for adults with type-2 diabetes whose blood sugar remains uncontrolled on one or more oral medicines in addition to diet and ...

The FINANCIAL -- A new study published in the Journal of Psychopharmacology, conducted by researchers from the University of Liverpool, Maastricht University and King’s College London, shows that ...